baber/WOPTO huggingface dataset:
Patent NZ-576697-A (NZ)
Title: Hydro-pnuematically damped descent apparatus
Inventor: MCCONNELL GEOFFREY NEIL
IPC: A62B1/00
Filed: 2010-05-20
Abstract: A descent apparatus (1) including a housing (3) with a liquid conduit (4) therethrough and a float (8) constrained within the liquid conduit (4) and capable of slideable movement along a first path between an upper and a lower position. A moveable element (6) is located outside the liquid conduit (4) and is slideably coupled to the housing (3). A mechanical connector (9) physically connects the movable element (6) to the float (8) such that in use, the liquid conduit (4) contains liquid and the position of the float (8) is variable by applying a force to the movable element (6) and wherein the slideable movement of the float (8) along a first path produces a corresponding movement of the moveable element (6) outside the housing (3) along a second path co-axial, or parallel with the first path.
Patent NZ-577071-A (NZ)
Title: Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Inventor: PETERS DAN
IPC: A61P25/00
Filed: 2007-12-18
Abstract: Disclosed is a compound of formula (I), wherein Q represents a chromen-2-one-yl group, wherein the chromene group is substituted with one heteroaryl group, and the other substituents are as defined in the specification.  The compounds are monoamine neurotransmitter re-uptake inhibitors useful in the treatment of CNS disorders.
Patent NZ-578521-A (NZ)
Title: Material and/or fuel produced from biomass
Inventor: PEUS DOMINIK
IPC: C10L5/44
Filed: 2007-12-28
Abstract: Disclosed is the use of an apparatus for treating a solid-fluid mixture of water and a carbon-containing component at a temperature of above 100oC and a pressure of above 5 bar, said apparatus comprising at least one reactor, characterized by a device for withdrawing water from the disperse solid phase by means of solid-fluid separation filtration process during the treatment to increase the carbon content of the solid-fluid mixture, to provide a fuel, humus or material suspension thereof increased in carbon content. Further disclosed is a method for the production of materials or fuels, humus or Maillard products of a solid-fluid mixture of water and a carbon-containing component, wherein the solid-fluid mixture is treated at a temperature of above 100oC and a pressure of above 5 bar, characterized in that the solid-fluid mixture is treated for a treatment period of at least 1 hour, wherein water parts are withdrawn from the disperse solid phase by means of solid-fluid separation filtration process during the treatment to increase the carbon content of the solid-fluid mixture.
Patent NZ-581669-A (NZ)
Title: Variable ratio transmission for providing a constant speed output from a prime mover input
Inventor: HICKS RAYMOND JOHN
IPC: F03D11/02
Filed: 2008-06-06
Abstract: Disclosed is a variable ratio transmission having an infinitely variable ratio, for enabling a wind or tidal turbine (10) or the like running at relatively low but continuously varying speeds to drive smoothly a constant speed machine, such as a synchronous generator or the like, without excessive transient torques. The transmission includes a primary differential gear train (120), having a driven input (50), and a driving output, wherein the ratio of the input speed to output speed is variable, and wherein the ratio is governed by the reaction torque provided by speed controlling gearing (150) within the primary differential. The transmission also includes a secondary differential gear train (220), which is in rotational communication with the input via a first route (115), and is in rotational communication with the speed controlling gearing via a second different route (125). The secondary differential gear train includes two parallel power paths P' and P'', one path includes a hydraulic bypass having two hydraulic units(180, 500) in a hydraulic circuit, the power transmitted and direction of power transmitted in the hydraulic circuit of the bypass path P' being selectively variable in use to vary the speed in path P'', thereby to alter the power in the second route and to alter the reaction torque of the speed controlling gearing and thereby to govern the ratio. The transmission makes use of the first and second routes for the whole input speed range.
Patent NZ-584912-A (NZ)
Title: New non-peptide derivatives as bradykinin b1 antagonists
Inventor: VAGO ISTVAN
IPC: C07D243/08
Filed: 2007-10-27
Abstract: The disclosure relates to bradykinin B1 receptor antagonist phenylsulfamoyl benzamide derivatives of formula (I), wherein R1 - R5, Q and Z are as defined in the specification, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which are selective antagonists of bradykinin B1, to processes for producing these compounds, to pharmacological compositions containing them and to their use in therapy or prevention of painful and inflammatory conditions.
Patent NZ-589122-A (NZ)
Title: Sweetener comprising a high intensity sweetener and taste modifying non-congruent flavour volatile
Inventor: CORLISS GLENN A
IPC: A23L27/30
Filed: 2009-05-11
Abstract: A sweetener comprising a high intensity sweetener and a taste modifying composition is disclosed, wherein the taste modifying composition comprises at least one non-congruent flavour volatile, wherein the at least one non-congruent flavour volatile is selected from the group consisting of alpha ionone, allyl alpha-ionone, cycloionone, dehydrodihydroionone, dihydro-alpha-ionone, dihydro-beta-ionone, dihydromethyl-alpha-ionone, dimethylionone, (E)-6,10-dimethylundeca-5,9-dien-2-one, gamma ionone, gamma-methyl ionone, ionone, alpha-ionone, beta-ionone , trans-beta-ionone, beta-ionone epoxide, gamma-ionone, alpha-irone, isobutylionone, alpha-isomethylionone, beta-isomethylionone, methylionone, methyl-alpha-ionone, alpha-methyl-ionone, methyl-beta-ionone, methyl-delta-ionone, methyl alpha-iononylglycidate, beta-methylionone diethyl ketal, methylisopseudoionone, pseudomethylionones, 3,4,5,6-tetrahydropseudoionone, pseudoionone raspberry essence, raspberry seed extract, jasmine absolute, boronia absolute and mixtures thereof; and wherein the taste modifying composition may further comprise at least one congruent flavor volatile such as vanillin, vanilla extract, maltol, sugar distillate, molasses distillate, malt distillate, coffee furanone, beeswax absolute, honey distillate, rum absolute and other similar compounds.
Patent NZ-590021-A (NZ)
Title: Re-closable end lid for a can with a rotatable opening and a tab which can be pressed into the opening tor re-seal the tab
Inventor: WICHELHAUS ANDRE
IPC: B65D39/04
Filed: 2008-09-11
Abstract: Disclosed is a re-closable can end lid with a rotatable opening and re-sealing tab, and drink can equipped with the re-sealable can end lid. A lid plate (2) includes a break-away portion (8) surrounded by a predetermined break-line (9) that is separable from the lid plate by the press portion (21) of an opening tab (20) in an opening position of the tab, so that an aperture (10) is created in the lid plate that is surrounded by a ring-wall (11) on the outside of the predetermined break-line. On a grip portion (22) of the opening tab, a sealing attachment is formed that, after rotating the opening tab into a closing rotating position, fits into a recess surrounded by the ring-wall and sealingly engages on the inner face of the ring-wall along its outer circumferential sealing rim.
Patent NZ-590973-A (NZ)
Title: Method to remove void spaces and vapours from carbonaceous materials, such as coal, comprising the comminution and compaction of the material
Inventor: FRENCH ROBERT R
IPC: B02C19/00
Filed: 2006-04-28
Abstract: Disclosed is a method of removing void spaces and vapours present in carbonaceous materials including the steps of: comminuting a carbonaceous material (such as coal, especially low rank coal, LRC) to form a crushed material in a counter-rotating roll compaction machine to produce a compact having reduced interstitial voids and gases; and, compacting the crushed material by feeding the crushed material between two counter-rotating rolls to produce a compact having reduced interstitial voids and gases, wherein the counter-rotating rolls provide a compaction pressure to the crushed material of between about 3,000 psi and about 80,000 psi, wherein the crushed material is compacted for between about 0.001 seconds and about 10 seconds; and, separating vapours from the compact in a gas/solids separator to form a dried carbonaceous product.
Patent NZ-591635-A (NZ)
Title: Administration of agents that bind to an alpha-4 integrin for the treatment of inflammation
Inventor: TAYLOR JULIE
IPC: A61K31/52
Filed: 2003-02-25
Abstract: Provided is the use of an agent selected from an antibody or an immunologically active fragment thereof which binds to alpha-4 integrin or a dimer comprising alpha-4 integrin for preparation of a medicament for the chronic treatment of pathological inflammation associated with disorders selected from the group consisting of asthma, atherosclerosis, AIDS, dementia, diabetes, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, chronic prostatitis, complications from sickle cell anemia, lupus erythematosus, and acute leukocyte mediated lung injury in a patient, wherein the medicament contains a therapeutically effective amount of the agent and is formulated for chronic administration, and wherein the chronic administration is for a period of at least 6 months.
Patent NZ-591710-A (NZ)
Title: Controlled release oral dosage form comprising at least one portion that is rapidly disintegrating and at least one portion that is slowly disintegrating
Inventor: LINDELL KATARINA
IPC: A61K9/24
Filed: 2009-10-13
Abstract: Disclosed is a multi portion intra-oral dosage form where: at least one portion is rapidly disintegrating and at least one portion is slowly disintegrating, the disintegration time for the slowest disintegrating portion is at least two times longer than for the most rapidly disintegrating portion, and each portion comprises at least one item selected from the following items: a pharmaceutically active component, a nicotine mimicking component, a pH-buffering component, a pH-regulating component, a flavour, a barrier component, a colour component, an adhesive component, a taste masking agent, a tooth whitening agent, a breath freshening agent, an oral health promoting agent, an anti-caries agent, and an anti-inflammatory agent, and the rapidly disintegrating portion comprises at least 40 per cent by weight of a compressible excipient selected from isomalt, dextrose monohydrate, maltodextrin, lactose monohydrate, dextrin, mannitol, lactitol, sorbitol, xylitol, erythritol, sucrose, and lactose, and mixtures thereof, and the at least one rapidly disintegrating portion further comprises a water-swellable excipient selected from sodium starch glycolate, crospovidone, croscarmellose, microcrystalline cellulose, starches, hydroxypropyl cellulose, and alginic acid, the weight ratio of the compressible excipient to the water-swellable excipient is from about 10:1 to about 500:1.
Patent NZ-592236-A (NZ)
Title: Ostomy pouch appliance
Inventor: FATTMAN GEORGE
IPC: A61F5/443
Filed: 2009-11-30
Abstract: 592236 A coupling assembly for fastening an adhesive wafer (34) to an ostomy appliance device (32), the coupling assembly including a captive connection (54) between the adhesive wafer and ostomy appliance that permits captive relative displacement between the entire adhesive wafer and the entrance aperture (42) of the appliance, to facilitate access to the wafer from the non-body-contacting side substantially without obstruction by the ostomy appliance. The limited motion connection is present in the coupling assembly in the operation position and in the access position. The coupling assembly further comprises a fixation coupling (56) for fixing the adhesive wafer in the operative position.
Patent NZ-592506-A (NZ)
Title: Coated glass surfaces and method for coating a glass substrate
Inventor: STULL RANDY LELAND
IPC: C03C17/00
Filed: 2009-11-03
Abstract: Disclosed herein is an article comprising a substrate and a coating applied to the substrate outwardly, comprising a bottom metal oxide layer; a layer of a Nickel-Chromium-Molybdenum alloy; a first silver layer; a middle metal oxide layer; a second silver layer; and a top metal oxide layer, wherein the coating comprises no more than two silver layers, and wherein the article has an emissivity of 0.030 to 0.039 and methods for its preparation. Also disclosed is a substrate coating on a glass substrate, the substrate coating comprising a plurality of layers on the glass substrate, the plurality of layers comprising: a first layer comprising a metal oxide, a second layer comprising a Nickel-Chromium-Molybdenum and Nb+Ta alloy comprising 8% to 10% Molybdenum and 3.15 % to 4.15% Nb+Ta by weight, and a third layer comprising silver, wherein the second layer comprising the alloy is between the first layer comprising the metal oxide and third layer comprising silver in the plurality of layers on the glass substrate.
Patent NZ-596002-A (NZ)
Title: Device for connecting a plastic tube to a connection nipple
Inventor: RATSCHMANN ELMAR
IPC: F16L13/14
Filed: 2010-06-01
Abstract: 596002 This application relates to a device for connecting a plastic tube (1) to a connection nipple (2). The connection end (4) of the plastic tube (1), provided with a front-side chamfered element (8) in the region of the inner diameter, is axially fixed between the connection nipple (2) and a clamping sleeve (3) by the insertion of at least one sealing ring (5) held in the profiled connection nipple (2). In order to create advantageous connection conditions, the connection nipple (2) has at least one radially outwardly projecting abutment that can be moved radially inwardly by means of the front-side chamfered element (8) in the region of the inner diameter of the connection end (4), the abutment (14) being arranged upstream of the sealing ring (5) in the insertion direction.
Patent NZ-600256-A (NZ)
Title: Fexofenadine microcapsules and compositions containing them
Inventor: MAPELLI LUIGI
IPC: A61K9/50
Filed: 2010-12-01
Abstract: Disclosed herein is a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating such as ethylcellulose, polyvinyl acetate, cellulose acetate, cellulose acetate butyrate, polyvinyl acetate, ammonio-methacrylate copolymers and mixtures thereof. In one embodiment the microcapsules are co-granulated with an inactive ingredient such as surcrose or xylitol. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
Patent NZ-606740-A (NZ)
Title: A virtual 3d paper
Inventor: KA YAN SO
IPC: G06F3/0484
Filed: 2013-02-07
Abstract: Disclosed is a virtual 3D paper (26). The paper (26) has a data reader that obtains data, and a multi touch gesture recognition engine that receives and recognizes multi-point touch signals. An event dispatching engine dispatches events in accordance with the action of the multi touch gesture recognition engine. An editing module edits data obtained by data reader which is then rendered by a rendering module. The rendering module includes a live content rendering engine for rendering content and a 3D graphic rendering engine that generates 3D rendered graphics. A display (25) displays the rendered results of the rendering module and a data exporter exports the rendered results.
Patent NZ-607880-A (NZ)
Title: Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
Inventor: KOGANOV MICHAEL
IPC: A61K36/28
Filed: 2007-02-21
Abstract: 607880 Disclosed is a bioactive ingredient comprising: an isolated bioactive fraction derived from cell juice of fresh biomass of a feverfew (Tanacetum parthenium) plant, wherein said bioactive fraction is either free of or substantially free of a-unsaturated y-lactones, said alpha-unsaturated gamma-lactones comprising parthenolide, and wherein said bioactive fraction has anti-inflammatory and antioxidant activity.
Patent NZ-607886-A (NZ)
Title: Nogo receptor binding protein
Inventor: MI SHA
IPC: A61K38/00
Filed: 2004-03-17
Abstract: Disclosed is the use of an Sp35 antagonist in the preparation of a medicament for treating a CNS disease, disorder or injury. Further disclosed is a pharmaceutical composition comprising an antibody or antigen binding fragment thereof that specifically binds to SEQ ID NO: 2, an LRR domain of Sp35 or the Ig domain of Sp35.
Patent NZ-610147-A (NZ)
Title: Oral dosage forms including an antiplatelet agent and an acid inhibitor
Inventor: GOLDSMITH MARK A
IPC: A61K9/48
Filed: 2007-04-04
Abstract: Disclosed is the use of an adenosine diphosphate (ADP) or P2Y12 antagonist and a proton pump inhibitor (PPI) for the manufacture of a pharmaceutical composition for treating or preventing a thrombotic disorder in a patient who does not have a symptom of gastrointestinal bleeding or a gastrointestinal ulcer, wherein the pharmaceutical composition is a single unit oral dosage form comprising: an amount of the ADP or P2Y12 antagonist effective to inhibit platelet aggregation, wherein said ADP or P2Y12 antagonist is clopidogrel or a pharmaceutically acceptable salt, ester, solvate, polymorph, hydrate, or enantiomer thereof; and an amount of proton pump inhibitor effective to reduce the risk of developing a gastrointestinal disorder associated with said ADP or P2Y12 antagonist, wherein said PPI is omeprazole or a pharmaceutically acceptable salt, ester, solvate, polymorph, hydrate or enantiomer thereof; wherein the PPI is enterically coated; and wherein the single unit oral dosage form does not include aspirin. Also disclosed is a unit dosage form comprising clopidogrel or pharmaceutically acceptable salt, ester, solvate, polymorph, hydrate or enantiomer thereof and omeprazole, or pharmaceutically acceptable salt, ester, solvate, polymorph, hydrate or enantiomer thereof.
Patent NZ-612670-A (NZ)
Title: Display
Inventor: PETER HASSETT
IPC: G09F5/00
Filed: 2013-06-28
Abstract: A retail display (10) displaying a range of colours for selection by a consumer, the display (10) including a base (12) and a display panel (16), the base including a mounting panel (22) and coupling means (14) for removably attaching the display panel (16) to the mounting panel (22), wherein the display panel displays said range of colours, and wherein the range of colours is a range of colours of paints, displayed by paint swatches for selection, removal and comparison by the consumer, wherein the coupling means (14) includes an aperture (24) formed in the mounting panel (22), and the display panel (16) includes a lug (42) adapted to engage with the aperture (24).
Patent NZ-620866-A (NZ)
Title: Compacted muriate of potash fertilizers containing micronutrients and methods of making same
Inventor: FERGUSON DEL
IPC: C05F11/00
Filed: 2012-08-02
Abstract: Disclosed is a granular cohered muriate of potash (MOP) fertilizer (potassium chloride) comprising boron. The cohered MOP composition is then further processed, such as by crushing and sizing, to form a cohered granular MOP product containing micronutrients. The process yields a fertilizer product containing micronutrients with superior elemental and granule size distribution without comprising handling or storage qualities.
Patent NZ-621357-A (NZ)
Title: Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
Inventor: DOMINGUEZ CELIA
IPC: C07D239/47
Filed: 2012-08-28
Abstract: Disclosed herein are the pyrimidine derivative compounds: 6-(4-Chloro-3-fluoro-phenyl)-pyrimidine-4-carboxylic acid; 6-(4-Chloro-phenyl)-pyrimidine-4-carboxylic acid; 6-(4-Chloro-2-fluoro-phenyl)-pyrimidine-4-carboxylic acid; 6-(3-Bromo-phenyl)-pyrimidine-4-carboxylic acid; 6-Naphthalen-2-yl-pyrimidine-4-carboxylic acid; and 6-Biphenyl-3-yl-pyrimidine-4-carboxylic acid; and the salts 6-(3-Bromo-phenyl)-pyrimidine-4-carboxylic acid sodium salt; and 6-(3,4-Difluoro-phenyl)-pyrimidine-4-carboxylic acid anion, sodium salt. Also provided are pharmaceutical compositions comprising the compounds or salts. The compounds are intended for the treatment of conditions mediated by kynurenine 3-monooxygenase, which include neurodegenerative disorders such as Huntington’s disease.
Patent NZ-623606-A (NZ)
Title: Antibody formulations and methods
Inventor: GARIDEL PATRICK
IPC: C12P21/08
Filed: 2012-10-25
Abstract: Disclosed is a lyophilised formulation of an antibody, comprising (a) a humanized version of antibody 2A4 (ATCC Accession Number PTA-9662) or antigen binding fragment thereof, or antibody 7D8 (ATCC Accession Number PTA-9468) or antigen binding fragment thereof; (b) L-histidine; (c) L-histidine HCl monohydrate; (d) trehalose; and (e) polysorbate 20, in such amounts, which upon reconstruction yield an aqueous solution wherein: (i) the antibody is present at a concentration within the range from 5 mg/ml to 15 mg/ml; (ii) a histidine buffer is present at a concentration within the range from 20 mM to 30 mM; 15 (iii) the trehalose is present at a concentration within the range from 210 mM to 250 mM; (iv) the polysorbate 20 is present at a concentration within the range from 0.005% to 0.05% by weight; and wherein the aqueous solution has a pH within the range from 6 to 7.
Patent NZ-630740-A (NZ)
Title: Pressure sensor evaluation for respiratory apparatus
Inventor: KENYON BARTON JOHN
IPC: G01L27/00
Filed: 2013-06-27
Abstract: Disclosed is a method for determining accuracy of a pressure sensor (104) in a respiratory device (100). The respiratory device (100) includes a flow generator (130) which comprises a motor configured to generate a pressurised flow of breathable gas. The method comprises measuring pressure of the flow of breathable gas generated by the flow generator using the pressure sensor (104); and determining accuracy of the pressure sensor (104) based on the measured pressure and an altitude of the respiratory device using a processor (116).
Patent NZ-630847-A (NZ)
Title: Anti-sema4d antibodies and epitopes
Inventor: SMITH ERNEST S
IPC: A61K39/395
Filed: 2013-03-27
Abstract: Disclosed is an isolated synthetic scaffold peptide comprising (i) SEMA-4D conformational epitope formed by the three amino acid sequences set forth in SEQ ID NO:18 (LKVPVFYALFTPQLNNV), SEQ ID NO:20 (KWTSFLKARLIASRP) and SEQ ID NO:22 (EFVFRVLIPRIARV); and (ii) a chemical linker that joins the amino acid sequences, wherein an anti-SEMA4D antibody binds the SEMA4D epitope.
Patent NZ-700984-A (NZ)
Title: N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
Inventor: BROOKFIELD FREDERICK ARTHUR
IPC: C07D249/12
Filed: 2007-03-16
Abstract: The disclosure relates to N-hydroxylsulfonamide derivatives represented by the structural formula (I) shown herein, wherein the variables are as defined in the specification. These compounds are suitable for treating, preventing, delaying the onset of, or delaying the development of a disease or condition that is responsive to nitroxyl therapy in an individual in need thereof, wherein the disease or condition is a cardiovascular disease or condition such as heart failure.